Status: Recruiting
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
The purpose of this study is to evaluate the safety, tolerability, and PK of RM-718 in healthy subjects with obesity and in patients with MC4R Pathway Impairment
Participants needed: 150
Trial details
Phase: Phase 1, Phase 2Age: 12-65Biological sex: AllType: InterventionalSponsor: Rhythm Pharmaceuticals, Inc.Updated: Dec 22, 2025Locations: 7
Eligibility criteria
Male and female subjects in good health aged 18-55 years of age at Screening. [+14]
Any clinically significant abnormalities on screening laboratories or physical e... [+23]